An evaluation study has examined the immunomodulatory effects of novel phosphinic acid derivatives in vitro and in a murine colitis model, according to PubMed imaging informatics data.
The findings are detailed in the journal Biomedicine & pharmacotherapy, dated August 20, 2026, and authored by Zhao X.